Autologous conditioned serum reduces bone tunnel enlargement after ACL reconstruction .
This report has been verified
by one or more authors of the
original publication.
Intraarticular application of autologous conditioned serum (ACS) reduces bone tunnel widening after ACL reconstructive surgery in a randomized controlled trial
Knee Surg Sports Traumatol Arthrosc. 2011 Dec;19 Suppl 1:S36-46. doi: 10.1007/s00167-011-1458-4. Epub 2011 Mar 1Exclusive Author Interview
Dr. Darabos speaks about the use of autologous conditioned serum to reduce bone tunnel enlargement following ACL reconstruction.
62 patients were randomized to examine whether the intraarticular administration of autologous conditioned plasma (ACS) could affect postoperative outcome from anterior cruciate ligament (ACL) reconstruction. Patients received either 2 mL of autologous conditioned serum or 2 mL of saline and were assessed after 12 months. Results indicated that there were significant differences in favour of the autologous conditioned serum treatment regarding the reduction in bone tunnel enlargement and improvement of WOMAC stiffness.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
